szacunkowo zwiedziła 0% świata (0 państw)

The substantial increase in cardiometabolic risk factors among the population is driving the global generic drugs market. Furthermore, diabetes, dyslipidaemia, hypertension, metabolic syndrome, and obesity are becoming more common because of various factors such as changing dietary habits, sedentary lifestyles, and hectic work schedules. This has resulted in a major increase in the uptake of medicines, accelerating the industry’s growth.